BridgeMD
New treatment option for Hip Fractures
Official title Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.
ClinicalTrials.gov ID: NCT06183541
What this study is testing
- What it's testing
- In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate of the PENG block in postoperative pain will be evaluated.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 85
You may be able to join if
- Patients who will undergo hip fracture surgery Women and men aged 30-85
You likely can't join if
- Patients under 30 years old, over 85 years old
- American Society of Anesthesiology (ASA) IV,
- Those with cognitive impairment (alzheimer, dementia, delirium, etc.)
- Those with application site infection
- Those who are allergic to local anesthetic substances
- Patients are non-consenting patients.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Umraniye, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Umraniye, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.